Clinical Trials Logo

Knee Osteoarthritis clinical trials

View clinical trials related to Knee Osteoarthritis.

Filter by:

NCT ID: NCT05949489 Recruiting - Knee Osteoarthritis Clinical Trials

Psychological and Pain Factors in Knee Osteoarthritis

Start date: July 15, 2023
Phase:
Study type: Observational

This study aims to determine if baseline measures of psychology and pain sensitivity can predict changes in physical function at 1 year in patients with knee osteoarthritis.

NCT ID: NCT05946434 Completed - Knee Osteoarthritis Clinical Trials

Effects of KT and Rigid Taping in Knee OA.

Start date: January 15, 2023
Phase: N/A
Study type: Interventional

The purpose of the study is to compare the effects of kinesio taping and rigid taping in Knee Osteoarthritis to alleviate symptoms like pain, reduce range of motion and functional limitations. A randomized control trial was conducted at Atta Memorial Hospital, Airport Society, Rawalpindi and Makkah Medical Complex, Rawalpindi. The sample size was 36 calculated through G-Power. The participants were divided into two interventional groups each having 18 participants. The study duration was six months. Sampling technique applied was Non probability convenient sampling. Only 40 to 60 years' participants with grade 1-3 Knee Osteoarthritis according to kellgren-Lawrence scale were included in the study. Tools used in this study are Visual analogue scale, WOMAC Index, timed up and go test and Goniometer self-structured Questionnaire. Data was collected before and immediately after the application of intervention on First day and then again at the end of session on 14th and 28th day. Data analyzed through SPSS version 23.

NCT ID: NCT05944627 Not yet recruiting - Knee Osteoarthritis Clinical Trials

Evaluate Safety and Explore Efficacy of FURESTEM-OA Kit Inj. in Patients With Knee Osteoarthritis

Start date: July 6, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

A Single, Dose Escalation, Optimal Dose Finding Phase I/IIa Clinical Trial to Evaluate Safety and Explore Efficacy of the Single Treatment of FURESTEM-OA Kit Inj. in Patients with Knee Osteoarthritis

NCT ID: NCT05941117 Completed - Knee Osteoarthritis Clinical Trials

Effect of Exercises on Dynamic Balance in Knee Osteoarthritis Patients.

Start date: October 25, 2022
Phase: N/A
Study type: Interventional

This study is a randomized controlled trial which aims to compare the effect of weight bearing exercises and non-weight bearing exercises on the dynamic balance in knee osteoarthritis patients as 60 patients will divided in three groups where one group is control group and others two groups one of them perform weight bearing exercises and the other perform non weight bearing exercises.

NCT ID: NCT05940246 Recruiting - Knee Osteoarthritis Clinical Trials

Investigating the Role of Motivational Interviewing in Swedish Patients Undergoing Knee Arthroplasty

Start date: April 28, 2022
Phase: N/A
Study type: Interventional

Knee arthroplasty is a successful surgical treatment for end-stage osteoarthritis. Most patients are satisfied with the result, however, 10% of the patients have remained dissatisfied over the last decades despite the advantages of the surgical procedure. Previous studies suggest that rehabilitation needs to be individualized and that some patients request additional support. Patient empowerment is a patient-centered strategy to increase, amongst other, patient engagement, participation, and motivation. Patient empowerment can be defined as a "process that helps people gain control over their own lives and increases their capacity to act on issues that they themselves define as important". One way of increasing patient empowerment is through motivational interviewing. Motivational interviewing is an evidence-based approach in which patients are supported to identify behavior changes toward their own individual goals. The aim of this study is to investigate if motivational interviewing could increase satisfaction in patients undergoing knee arthroplasty. Furthermore, we want to examine role MI in this patient group with interviews of both MI-practitioners and patients as well as detailed investigations about the MI sessions.

NCT ID: NCT05936060 Not yet recruiting - Knee Osteoarthritis Clinical Trials

Cartilage Recovery in Adults With Knee Osteorthritis by Mesenchymal Cell Therapy: Randomized Trial of Radiologic and Clinical Outcomes

INMUNOCEM-OA
Start date: October 1, 2023
Phase: Phase 2
Study type: Interventional

The treatment of osteoarthritis (OA) of the knee remains still controversial. Despite that fact advanced stages with symptomatic and functional improvement are obtained with total knee replacement, however, there is no treatment that neither modifies the natural history of this disease, nor avoid joint replacement surgery in young patients in whom the prosthesis has conflictive indications. Moreover, prosthetic surgery leads to lower long-term survival and in older patients, higher morbidity and mortality. Cell therapy promises to be a treatment option through the use of mesenchymal cells with the capacity control inflammatory responses and trigger the differentiation into chondrocytes. Here we propose a randomized placebo-controlled clinical trial to evaluate radiologic and clinical outcomes in patients with knee OA.

NCT ID: NCT05933434 Recruiting - Knee Osteoarthritis Clinical Trials

Allogenic Mesenchymal Stem Cell Intraarticular Injection for Knee Osteoarthritis Therapy

STEMJOINT
Start date: March 7, 2024
Phase: Phase 1/Phase 2
Study type: Interventional

This phase I and II double blinded randomized clinical controlled trial investigates the safety and efficacy of intraarticular knee injection with allogenic adipose derived mesenchymal stem cells (AD-MSC), in patients suffering from mild-moderate knee osteoarthritis compared to placebo injection with saline.

NCT ID: NCT05929066 Recruiting - Obesity Clinical Trials

A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight

TRIUMPH-1
Start date: July 10, 2023
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of retatrutide in participants who have obesity or overweight (J1I-MC-GZBJ master protocol) including subsets of participants who have knee osteoarthritis (OA) (J1I-MC-GOA1) or who have obstructive sleep apnea (OSA) (J1I-MC-GSA1). This study will last about 89 weeks and will include up to 24 visits.

NCT ID: NCT05925517 Completed - Knee Osteoarthritis Clinical Trials

The Effect of Graded Motor Imagery on Pain and Function in Individuals With Knee Osteoarthritis

Start date: July 1, 2023
Phase: N/A
Study type: Interventional

The aim of this study is to investigate whether Graded Motor Imagery (GMI) application is as effective as Transcutaneous Electrical Nerve Stimulation (TENS) in individuals with knee osteoarthritis (OA). The objectives are to improve range of motion (ROM) and muscle strength, reduce pain and stiffness, increase pain pressure threshold, and enhance function and physical performance through GMI application.

NCT ID: NCT05924412 Recruiting - Knee Osteoarthritis Clinical Trials

Parecoxib in Total Knee Arthroplasty

Start date: July 6, 2023
Phase: Phase 4
Study type: Interventional

Early mobilization and rehabilitation can be difficult after total knee arthroplasty (TKA) due to a high incidence of moderate to severe postoperative pain. Non-steroidal anti-inflammatory drugs (NSAIDs) are important to multimodal analgesic protocols. Parecoxib is an NSAID that selectively inhibits the enzyme cyclooxygenase-2 (COX-2). Clinical trials have shown that it does not alter platelet function or gastric mucosa. A recent study, after comparing ketorolac and parecoxib used at the same time in infiltration and systemically, found no differences in perioperative analgesia with a tendency to less bleeding in the parecoxib group. This randomized study will compare the effectiveness of adding a COX-2 inhibitor in the pain management of patients undergoing TKA as part of a multimodal analgesia regimen. The morphine consumption was selected as the primary outcome. The study hypothesis is that patients receiving parecoxib would have a lower opioid consumption.